Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.19.3
Consolidated Balance Sheets - USD ($)
Jun. 30, 2019
Jun. 30, 2018
Current assets:    
Cash $ 30,142 $ 48,440
Accounts receivable (net of allowance of $0 and $0, respectively) 45,086
Inventories 406,439 103,209
Other current assets 1,000 3,210
Total current assets 482,667 154,859
Total assets 482,667 154,859
Current liabilities:    
Accounts payable 496,809 215,782
Accrued expense-related party 33,974 197,974
Convertible notes payable-net of debt discounts and unamortized beneficial conversion feature 1,117,741 633,870
Fair value of derivative liabilities 1,306,748 1,765,187
Short-term borrowings 1,000
Total current liabilities 29,955,272 2,813,813
Commitments and contingencies
Stockholders' deficit:    
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 53,773,856 issued and outstanding as of June 30, 2019 and 42,608,329 outstanding as of June 30, 2018, respectively) 53,774 42,608
Preferred stock, ($0.001 par value, 100,000,000 shares authorized, and 1,000 issued and outstanding as of June 30, 2019 and 0 outstanding as of June 30, 2018, respectively) 1
Additional paid in capital 10,692,679 5,919,152
Accumulated deficit (13,219,059) (8,620,714)
Total stockholders' deficit (2,472,605) (2,658,954)
Total Liabilities and Stockholders' Deficit $ 482,667 $ 154,859